Nortriptyline Capsules Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 10 mg, 25 mg, 50 mg, 75 mg
Reference Brands: Pamelor®(US); Nortrilen®(EU)
Category:
Antipsychotropic Drugs
Nortriptyline is a tricyclic antidepressant (TCA) that works by inhibiting the reuptake of norepinephrine and serotonin, enhancing mood-regulating neurotransmission. It is primarily used to treat major depressive disorder (MDD) and is also prescribed for neuropathic pain and migraine prevention. It may cause anticholinergic side effects and requires careful dose adjustment.
Nortriptyline Capsules is available in Capsules
and strengths such as 10 mg, 25 mg, 50 mg, 75 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nortriptyline Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nortriptyline Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
In the United States, nortriptyline capsules are FDA-approved for the treatment of major depressive disorder (MDD). As a tricyclic antidepressant (TCA), it carries a Boxed Warning about increased risk of suicidal ideation in children, adolescents, and young adults. Regulatory compliance includes GMP manufacturing, bioequivalence studies for generics, and post-marketing safety surveillance.
In the European Union, nortriptyline capsules are approved via national regulatory pathways for depression and off-label uses like chronic pain. EU guidelines require a valid Risk Management Plan (RMP), pharmacovigilance reporting, and labelling aligned with EMA safety standards. For global sourcing and compliant supply, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing